Healthcare Buy Side Mergers and Acquisitions

Handle structures and executes Healthcare Buy Side Mergers and Acquisitions for family enterprises, private capital, strategics, and sovereign-adjacent investors operating through the UAE. We align clinical, regulatory, and financial diligence into one mandate; from target origination to close and post-close integration.

Our model is built for boards that cannot tolerate regulatory drift or earnings surprises. We underwrite healthcare assets with evidence, control contractual risk, and structure governance for continuity; hospitals, clinics, laboratories, pharma, medtech, healthtech, and integrated platforms brought under one disciplined acquisition playbook.

Healthcare transactions are not generic M&A. They combine clinical risk, regulator scrutiny, complex licensing, and people-critical operations. Handle leads these mandates with a framework that connects law, capital, and healthcare operations into one controlled acquisition program.

We do not chase deal volume. We build positions that stand scrutiny from regulators, lenders, minority shareholders, and medical leadership. The outcome is precise: executable deals, controlled integration, and defensible value at scale.

• Healthcare-native diligence: clinical quality, licensing, payor mix, and referral dynamics analysed with financial discipline
• Regulatory alignment across UAE health authorities and free zone regulators
• Integrated view of legal, tax, and structuring risk around physicians, partnerships, and assets
• Capital and debt structuring aligned with reimbursement cycles and capex intensity
• Post-close governance and management architecture designed before signing
• One statement of work: from pipeline to integration, managed under a single accountable team

We lead Healthcare Buy Side Mergers and Acquisitions as a single integrated mandate, connecting strategy, origination, diligence, legal structuring, and integration into one controlled execution path.

The objective is constant: acquire assets that regulators approve, clinicians respect, and capital providers can underwrite; with governance and performance engineered in from the outset.

• Buy-side strategy and thematic thesis development across GCC and broader Middle East healthcare
• Target mapping, outreach, and pipeline curation for hospitals, clinics, labs, imaging, pharma, medtech, and healthtech
• Integrated diligence command: financial, commercial, clinical, regulatory, HR, IT, and tax
• Transaction structuring, SPA/APA negotiation, shareholder arrangements, and management incentive design
• Regulatory and competition filings, licensing transfers, and approvals coordination in UAE-linked jurisdictions
• Day-one readiness, integration blueprint, and post-close governance and reporting architecture